HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3

HAEMONETICS CORP

Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Aug 6, 2026

$118.73+0.45 (+0.38%)

Close on Oct 19, 2026

Market cap: $5.43B
P/E (TTM): 57.9
Dividend yield: –

HAEMONETICS CORP balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-03-28	FY 2025 2025-03-29	FY 2024 2024-03-30	FY 2023 2023-04-01	FY 2022 2022-04-02	FY 2021 2021-04-03	FY 2020 2020-03-28	FY 2019 2019-03-30	FY 2018 2018-03-31	FY 2017 2017-04-01	FY 2016 2016-04-02	FY 2015 2015-03-28	FY 2014 2014-03-29	FY 2013 2013-03-30	FY 2012 2012-03-31	FY 2011 2011-04-02	FY 2010 2010-04-03	FY 2009 2009-03-28	FY 2008 2008-03-29
Cash & Equivalents	245	307	179	284	259	192	137	169	180	140	115	161	192	179	229	197	142	157	134
Cash & Short-Term Investments	245	307	179	284	259	192	137	169	180	140	115	161	192	179	229	197	142	157	134
Receivables	217	203	207	179	159	128	165	185	151	153	157	146	165	170	135	127	119	–	–
Inventory	306	365	317	259	293	323	270	194	161	177	187	211	198	184	117	84	80	–	–
Prepaid Expenses & Other	66	60	66	47	44	51	31	27	29	41	29	40	54	50	36	31	–	–	–
Other Current Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	31	35	–	–
Total Current Assets	835	935	769	770	756	694	604	576	521	510	488	558	623	597	527	449	386	–	–
Property, Plant & Equipment	306	284	311	311	258	218	253	344	332	324	338	322	271	257	162	156	154	–	–
Gross Property, Plant & Equipment	842	837	959	944	869	817	832	933	873	807	786	732	702	633	511	476	444	–	–
Accumulated Depreciation	-536	-553	-648	-633	-611	-600	-579	-589	-541	-484	-449	-410	-430	-376	-349	-320	-290	–	–
Machinery & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	206	136	129	114	–	–
Operating Lease Right-of-Use Assets	40	47	55	53	53	60	52	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	656	604	565	466	467	466	211	211	211	211	268	334	337	330	115	115	110	–	–
Intangible Assets	448	456	406	276	310	365	133	128	157	178	204	245	271	264	97	102	100	–	–
Deferred Tax Assets	9.52	7.80	7.74	5.24	4.47	6.01	3.93	4.36	3.96	3.99	7.06	16	1.18	1.75	0.02	1.29	0.91	–	–
Other Long-Term Assets	142	164	136	107	63	71	62	12	12	12	14	11	11	11	11	10	9.72	–	–
Total Assets	2,396	2,451	2,196	1,935	1,860	1,820	1,267	1,275	1,237	1,239	1,319	1,485	1,514	1,462	911	833	764	–	–
Accounts Payable	51	67	73	64	58	50	51	63	55	43	40	48	54	50	35	28	26	–	–
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	0	5.60	–	–	–	–	–
Current Portion of Long-Term Debt	5.02	304	10	12	214	17	77	28	194	61	43	22	46	23	0.89	0.91	16	–	–
Current Debt	5.02	304	10	12	214	17	77	28	194	61	43	22	46	29	0.89	0.91	16	–	–
Current Portion of Leases	9.24	8.11	8.13	7.16	7.20	7.71	7.31	–	–	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	–	–	–	–	10	19	13	8.45	5.34	4.41	3.88	3.82	3.11	4.05	8.08	6.03	5.09	–	–
Deferred Revenue (Current)	42	43	31	30	27	26	29	27	26	26	27	22	–	–	–	–	–	–	–
Other Current Liabilities	158	148	136	112	121	139	98	92	66	64	67	68	60	57	57	46	49	–	–
Total Current Liabilities	283	578	300	252	442	253	275	236	385	211	186	189	217	180	131	109	135	–	–
Long-Term Debt	1,220	921	798	754	559	691	306	322	59	254	365	406	392	457	2.88	3.97	4.46	–	–
Long-Term Leases	41	50	58	56	56	63	52	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	50	59	66	63	63	71	59	–	–	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	38	63	63	36	29	44	11	20	6.53	12	21	33	30	30	23	19	15	–	–
Other Long-Term Liabilities	59	68	75	75	80	100	89	29	34	22	26	32	38	26	22	16	13	–	–
Total Liabilities	1,600	1,630	1,236	1,117	1,110	1,088	680	607	485	499	598	659	676	693	179	147	168	–	–
Total Debt	1,225	1,225	808	766	774	708	382	350	254	315	408	428	438	486	3.77	4.88	21	–	–
Common Stock	0.45	0.48	0.51	0.50	0.51	0.51	0.50	0.51	0.52	0.52	0.51	0.52	0.52	0.51	0.51	0.26	0.26	–	–
Additional Paid-In Capital	554	523	635	595	572	603	553	536	504	482	440	427	403	365	322	303	252	–	–
Retained Earnings	279	352	360	253	202	158	79	161	267	290	316	420	433	398	401	374	335	–	–
Comprehensive Income & Other	-38	-55	-36	-30	-26	-30	-45	-30	-19	-33	-35	-22	1.41	5.43	9.11	9.54	5.91	–	–
Shareholders' Equity	796	821	960	818	749	732	587	668	752	740	722	826	838	769	733	686	593	540	494
Total Equity	796	821	960	818	749	732	587	668	752	740	722	826	838	769	733	686	593	540	494
Total Liabilities & Equity	2,396	2,451	2,196	1,935	1,860	1,820	1,267	1,275	1,237	1,239	1,319	1,485	1,514	1,462	911	833	761	–	–
Shares Outstanding(shares)	45	48	51	50	51	51	50	51	52	52	51	52	52	51	51	51	51	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 27, 2026

Profitability, TTM

Gross margin: 59.0%
Operating margin: 11.9%
Net margin: 7.1%
Return on equity, FY2026: 12.0%

Financial strength

Current ratio: 3.08
Debt to equity: 1.40
Debt to assets: 49.6%
Cash to current liabilities: 84.9%

Valuation

P/E ratio: 57.9
Price to sales: 4.01
Price to book: 6.48
Dividend yield: –